Tetracyclic spirobenzazepine dopamine antagonists
US5158948A · kind A · utility
5Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 1991 |
| Grant date | Oct 27, 1992 |
| Priority date | — |
| Expiry date | Sep 19, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel tetracyclic spirobenzazepine compounds of the formula ##STR1## or a pharmaceutically-acceptable salt, amide or ester thereof, which are dopamine D-1 receptor antagonists useful for treating dopamine-related neurological and psychological disorders, cognitive impairment, attention deficit disorders and addictive behavior disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.